Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-17 Sale | 2020-08-19 7:40 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 30,000 | $109.74 | $3,292,196 | 3,853,396 (Indirect Direct) | View |
| 2020-08-17 Sale | 2020-08-19 7:40 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 30,000 | $109.74 | $3,292,196 | 4,225,079 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-22 Option Award | 2022-02-24 8:40 pm | N/A 2032-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Howarth Alex G. CFO | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 8:18 pm | N/A 2032-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Lynch Brian Joseph VP | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 8:18 pm | N/A 2032-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Sukhija Remy Chief Commercial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-24 8:17 pm | N/A 2022-02-24 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Waltermire Robert E. Senior VP Chief Pharma Dev. | 12,250 | $0 | 12,250 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 8:12 pm | N/A 2032-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca See Remarks | 61,500 | $0 | 61,500 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 8:10 pm | N/A 2032-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-02 4:05 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 0 | $0 | 1,981,140 (Indirect) | View |
| 2021-12-31 Ownership | 2022-02-02 4:05 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 3,000 | $0 | 1,981,140 (Direct) | View |
| 2021-12-03 Other | 2021-12-07 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 824,172 | $0 | 825,433 (Indirect) | View |
| 2021-12-03 Other | 2021-12-07 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 824,172 | $0 | 1,294,791 (Indirect) | View |
| 2021-11-01 Option Award | 2021-11-03 4:26 pm | N/A 2031-11-01 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Howarth Alex G. CFO | 5,000 | $0 | 5,000 (Direct) | View |
| 2021-08-02 Option Award | 2021-08-04 9:46 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Waltermire Robert E. Senior VP Chief Pharma Dev. | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:03 am | N/A 2024-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Daly James M Director | 12,489 | $0 | 12,489 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:03 am | N/A 2024-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director | 12,489 | $0 | 12,489 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:02 am | N/A 2024-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 12,489 | $0 | 12,489 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:02 am | N/A 2024-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | BATE KENNETH Director | 12,489 | $0 | 12,489 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:02 am | N/A 2024-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director | 12,489 | $0 | 12,489 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:00 am | N/A 2024-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Gollust Keith R Director | 12,489 | $0 | 12,489 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 3:40 pm | N/A 2031-05-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Howarth Alex G. CFO | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-23 1:35 pm | N/A 2031-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-23 1:32 pm | N/A 2031-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 32,000 | $0 | 32,000 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-23 1:31 pm | N/A 2031-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Sukhija Remy Chief Commercial Officer | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-23 1:29 pm | N/A 2031-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Lynch Brian Joseph VP | 32,000 | $0 | 32,000 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-23 1:28 pm | N/A 2031-02-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca See Remarks | 44,000 | $0 | 44,000 (Direct) | View |
| 2020-12-31 Ownership | 2021-02-11 3:50 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 0 | $0 | 2,733,100 (Indirect) | View |
| 2020-12-31 Ownership | 2021-02-11 3:50 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 15,000 | $0 | 2,733,100 (Direct) | View |
| 2020-12-01 Other | 2020-12-01 9:36 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 43,537 | $0 | 2,354,058 (Indirect) | View |
| 2020-09-04 Other | 2020-09-04 9:09 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 1,545,460 | $0 | 1,638,727 (Indirect) | View |
| 2020-09-04 Other | 2020-09-04 9:06 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 1,545,460 | $0 | 2,049,013 (Indirect) | View |
| 2020-08-06 Option Award | 2020-08-10 7:07 pm | N/A 2030-08-06 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Lynch Brian Joseph See Remarks | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 07:53 am | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Daly James M Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 07:49 am | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Gollust Keith R Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 07:46 am | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | BATE KENNETH Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 07:43 am | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 07:41 am | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 07:39 am | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-05-27 Other | 2020-05-29 4:51 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 412,236 | $0 | 856,794 (Indirect) | View |
| 2020-05-27 Other | 2020-05-29 4:51 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 412,236 | $0 | 566,491 (Indirect) | View |